Risk of Venous Thromboembolism in Long-Term Care Residents: What Do We Know Now?

Journal of the American Medical Directors Association

Volumn 11, Issue 3, 2010, Pages 159-160

  Messinger Rapport, Barbara J ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 10A INHIBITOR; DALTEPARIN; FONDAPARINUX; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW MOLECULAR WEIGHT HEPARIN; PLACEBO; WARFARIN;

COMPRESSION GARMENT; EDITORIAL; HIGH RISK PATIENT; HUMAN; IMMOBILIZATION; LONG TERM CARE; MEDICAL CARE; SCREENING TEST; VENOUS THROMBOEMBOLISM;

EID: 77049085033     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.01.008     Document Type: Editorial

References (12)

1. Zarowitz B., Tangelos E., Lefkovitz A., et al. Thrombotic risk and immobility in residents of long-term care facilities. J Am Med Dir Assoc 11 (2010) 211-221
2. Geerts W.H., Bergqvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (2008) 381S-453S
3. Grady D., Wenger N., Herrington D.M., et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med 132 (2000) 689-696
4. Hull R.D., Schellong S.M., Tapson V.F., et al. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility: Methodology for the EXCLAIM study. J Thromb Thrombolysis 22 (2006) 31-38
5. Hull RD. EXCLAIM: Extended Prophylaxis for Venous ThromboEmbolism (VTE) in Acutely Ill Medical Patients With Prolonged Immobilization. Available at: http://www.clinicalstudyresults.org/drugdetails/?sort=inn.inn_name&page=7&drug_id=3424. Accessed January 18, 2010.
6. Vaitkus P.T., Leizorovicz A., Goldhaber S.Z., and Group P.I. Rationale and design of a clinical trial of a low-molecular-weight heparin in preventing clinically important venous thromboembolism in medical patients: The prospective evaluation of dalteparin efficacy for prevention of venous thromboembolism in immobilized patients trial (the PREVENT study). Vasc Med 7 (2002) 269-273
7. Leizorovicz A., Cohen A.T., Turpie A.G., et al. Randomized, placebo-controlled trial of dalteparin for the prevention of venous thromboembolism in acutely ill medical patients. Circulation 110 (2004) 874-879
8. Kucher N., Leizorovicz A., Vaitkus P.T., et al. Efficacy and safety of fixed low-dose dalteparin in preventing venous thromboembolism among obese or elderly hospitalized patients: A subgroup analysis of the PREVENT trial. Arch Intern Med 165 (2005) 341-345
9. Ray J.G., Lonn E., Yi Q., et al. Venous thromboembolism in association with features of the metabolic syndrome. QJM 100 (2007) 679-684
10. Petersen L.J. Anticoagulation therapy for prevention and treatment of venous thromboembolic events in cancer patients: A review of current guidelines. Cancer Treat Rev 35 (2009) 754-764
11. Phillips S.M., Gallagher M., and Buchan H. Use graduated compression stockings postoperatively to prevent deep vein thrombosis. BMJ 336 (2008) 943-944
12. Amaragiri S.V., and Lees T.A. Elastic compression stockings for prevention of deep vein thrombosis. Cochrane Database Syst Rev 3 (2000) CD001484